Unbound MEDLINE

Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives. Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] Journal article

 
TitleCorrelation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives.
Author(s)Koyama J, Nisino Y, Morita I, Kobayashi N, Osakai T, Tokuda H 
InstitutionFaculty of Pharmaceutical Sciences, Kobe Pharmaceutical University, Higashinada, Kobe 658-8558, Japan.
SourceBioorg Med Chem Lett 2008 Jun 2.
AbstractAs a continuation of studies using natural and synthetic products as cancer chemopreventive agents, we used cyclic voltammetry to examine the reduction-oxidation potentials of methylated emodin derivatives prepared from emodin in phosphate buffer at pH 7.2. A good correlation was found between the inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation and the reduction potential of methylated emodin derivatives. Furthermore, there was significant correlation between EBV-EA activation and the reduction potential of 35 anthraquinone derivatives including methylated emodin derivatives. It was further shown that the correlation could be enhanced by including LUMO energy and the number of hydroxy groups as additional parameters.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID18556196
  
Advertise on this site.